DMK Pharmaceuticals files for chapter 11 bankruptcy, shares plunge premarket

seekingalpha

Feb 05, 2024

DMK Pharmaceuticals (NASDAQ:DMK) and subsidiaries commenced bankruptcy cases by filing voluntary petitions under Chapter 11 of the U.S. Bankruptcy Code in the United States Bankruptcy Court for the District of Delaware.
The parties expect that the court will approve the relief sought in these motions on an interim basis, it said on Feb. 2.
DMK -20.90% premarket to $0.4113
Source: Press Release

More on DMK Pharmaceuticals

Seeking Alpha’s Quant Rating on DMK Pharmaceuticals
Historical earnings data for DMK Pharmaceuticals
Financial information for DMK Pharmaceuticals

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2409105377"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2409105377\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2409105377?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-02-05 17:28","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2409105377","market":"us","top_or_hot":-1,"title":"DMK Pharmaceuticals files for chapter 11 bankruptcy, shares plunge premarket","media":"seekingalpha","content":"<html><body><ul>\n<li>DMK Pharmaceuticals (<span>NASDAQ:DMK</span>) and subsidiaries commenced bankruptcy cases by filing voluntary petitions under Chapter 11 of the U.S. Bankruptcy Code in the United States Bankruptcy Court for the District of Delaware.</li>\n<li>The parties expect that the court will approve the relief sought in these motions on an interim basis, it said on Feb. 2.</li> <li>DMK  <font color=\"red\">-20.90%</font> premarket to  $0.4113</li>\n<li>Source: Press Release\n</li>\n</ul>\n<div>\n<h2>More on DMK Pharmaceuticals</h2> <ul> <li>Seeking Alpha’s Quant Rating on DMK Pharmaceuticals</li> <li>Historical earnings data for DMK Pharmaceuticals</li> <li>Financial information for DMK Pharmaceuticals</li> </ul>\n</div></body></html>","source":"seekingalpha_hot_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>DMK Pharmaceuticals files for chapter 11 bankruptcy, shares plunge premarket</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nDMK Pharmaceuticals files for chapter 11 bankruptcy, shares plunge premarket\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-02-05 17:28 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/news/4062420-dmk-pharmaceuticals-files-for-chapter-11-bankruptcy-shares-plunge-premarket><strong>seekingalpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>DMK Pharmaceuticals (NASDAQ:DMK) and subsidiaries commenced bankruptcy cases by filing voluntary petitions under Chapter 11 of the U.S. Bankruptcy Code in the United States Bankruptcy Court for the ...</p>\n\n<a href=\"https://seekingalpha.com/news/4062420-dmk-pharmaceuticals-files-for-chapter-11-bankruptcy-shares-plunge-premarket\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":null,"symbol_name":null,"start_time":0,"source_url":"https://seekingalpha.com/news/4062420-dmk-pharmaceuticals-files-for-chapter-11-bankruptcy-shares-plunge-premarket","article_id":"2409105377","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2409105377","pubTimestamp":1707125282,"columns":[],"sourceInfo":{"source_id":"seekingalpha_hot_news","name":"SeekingAlpha"},"weMediaInfo":null,"summary":"DMK Pharmaceuticals  and subsidiaries commenced bankruptcy cases by filing voluntary petitions under Chapter 11 of the U.S. Bankruptcy Code in the United States Bankruptcy Court for the District of Delaware.The parties expect that the court will approve the relief sought in these motions on an interim basis, it said on Feb. 2. DMK  -20.90% premarket to  $0.4113. More on DMK Pharmaceuticals  Seeking Alpha’s Quant Rating on DMK Pharmaceuticals Historical earnings data for DMK Pharmaceuticals Financial information for DMK Pharmaceuticals","collect":0,"end_time":0,"defaultTopTitle":"seekingalpha.com","property":[],"viewcount":null,"language":"en","relate_stocks":{},"translate_title":"DMK制药申请破产，股价盘前暴跌","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"DMK":1,"DMKPQ":1},"content_text":"DMK Pharmaceuticals (NASDAQ:DMK) and subsidiaries commenced bankruptcy cases by filing voluntary petitions under Chapter 11 of the U.S. Bankruptcy Code in the United States Bankruptcy Court for the District of Delaware.\nThe parties expect that the court will approve the relief sought in these motions on an interim basis, it said on Feb. 2. DMK  -20.90% premarket to  $0.4113\nSource: Press Release\n\n\n\nMore on DMK Pharmaceuticals  Seeking Alpha’s Quant Rating on DMK Pharmaceuticals Historical earnings data for DMK Pharmaceuticals Financial information for DMK Pharmaceuticals","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"}}}